Additional Funding to Develop a Drug for Alzheimer’s Disease
Additional Funding to Develop a Drug for Alzheimer’s Disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Huang Lab Mahley Lab Alzheimer’s Disease